Invest in Israel Newsletter March 2010 Edition
VC Cafe
APRIL 8, 2010
billion, and in 2005 it bought another generics competitor, Ivax, based in Miami, for about $7.4 The 2-year model, which was also backed by the Bank of Israel, will allow the government to present a long term plan and maintain market stability. Teva, Israel’s largest company, has a market value of about $56 billion.
68 
Let's personalize your content